Neuroblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
47
|
166
|
0.700 |
None |
0.957 |
13 |
|
2000 |
2020 |
Adenocarcinoma of lung (disorder)
|
disease |
Neoplasms
|
Neoplastic Process
|
206
|
404
|
0.700 |
None |
0.977 |
8 |
6
|
2008 |
2020 |
Inflammatory Myofibroblastic Tumor
|
disease |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
6
|
|
0.700 |
None |
0.966 |
4 |
|
1999 |
2019 |
Brain Neoplasms
|
group |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
39
|
122
|
0.610 |
None |
1.000 |
1 |
3
|
2009 |
2012 |
Non-Small Cell Lung Carcinoma
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
156
|
132
|
0.600 |
None |
0.990 |
28 |
|
2007 |
2020 |
NEUROBLASTOMA, SUSCEPTIBILITY TO, 3
|
disease |
|
Finding
|
1
|
16
|
0.600 |
definitive |
1.000 |
8 |
16
|
2008 |
2012 |
Ki-1+ Anaplastic Large Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
4
|
|
0.600 |
None |
0.973 |
6 |
|
1995 |
2020 |
Malignant neoplasm of brain
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
38
|
4
|
0.500 |
None |
1.000 |
1 |
|
2012 |
2012 |
Rhabdomyosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
15
|
4
|
0.500 |
None |
1.000 |
0 |
1
|
2009 |
2020 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
217
|
|
0.400 |
None |
0.983 |
2 |
|
2007 |
2020 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
148
|
19
|
0.400 |
None |
0.929 |
1 |
|
2012 |
2019 |
Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
128
|
119
|
0.400 |
None |
0.947 |
1 |
|
2012 |
2019 |
hereditary neuroblastoma
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms
|
Neoplastic Process
|
1
|
|
0.400 |
None |
0.933 |
1 |
|
2008 |
2018 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
527
|
316
|
0.400 |
None |
1.000 |
1 |
1
|
2016 |
2018 |
Anaplastic Large Cell Lymphoma, ALK-Positive
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1
|
|
0.400 |
None |
0.931 |
1 |
|
1999 |
2019 |
Diffuse Large B-Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
55
|
19
|
0.400 |
None |
1.000 |
1 |
|
2003 |
2018 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
538
|
763
|
0.390 |
None |
0.900 |
1 |
|
2002 |
2019 |
melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
248
|
212
|
0.390 |
None |
1.000 |
0 |
|
2015 |
2019 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1074
|
1390
|
0.370 |
None |
1.000 |
1 |
|
2009 |
2018 |
ALK positive large B-cell lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1
|
|
0.360 |
None |
1.000 |
0 |
|
2011 |
2017 |
Papillary thyroid carcinoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
86
|
12
|
0.350 |
None |
1.000 |
2 |
|
2012 |
2019 |
Inflammatory Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1
|
|
0.320 |
None |
1.000 |
1 |
|
2012 |
2015 |
Neoplasms, Intracranial
|
group |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
33
|
|
0.320 |
None |
1.000 |
1 |
|
2012 |
2019 |
Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
87
|
97
|
0.320 |
None |
1.000 |
0 |
|
2011 |
2017 |
Neural crest tumor
|
disease |
Neoplasms; Endocrine System Diseases
|
Disease or Syndrome
|
7
|
|
0.310 |
None |
1.000 |
1 |
|
2007 |
2008 |